OBJECTIVE: To study resting forearm venous plasma noradrenaline (NA) and 24 h sympathoadrenal activity evaluated by measurements of thrombocyte NA and adrenaline (A) in obese male subjects before and after weight reduction. DESIGN: Blood samples were collected in obese subjects and in controls after an overnight fast. MEASUREMENTS: Fatness and fat distribution parameters, plasma and thrombocyte NA and A, lymphocyte b b 2 -adrenoceptor mRNA, cAMP and lymphocyte subset composition. RESULTS: Forearm venous plasma NA at rest was signi®cantly elevated in the obese subjects and correlated to the body mass index and diastolic blood pressure. Thrombocyte NA and A correlated, however, negatively to the body fat % in obese subjects. Further analysis showed that thrombocyte NA and A were reduced in obese subjects with body fat % above 40% but not in the other groups. Weight reduction normalized both forearm venous plasma NA and thrombocyte NA and A. b b 2 -adrenoceptor mRNA correlated positively to the frequency of CD3 7 CD56 and CD3 CD8 cells in the blood and negatively to plasma A, but there was no difference in the mRNA level, cyclic AMP and lymphocyte subset composition between obese and controls. CONCLUSIONS: Sympathetic activity at rest as evaluated by forearm venous plasma NA was increased in the obese male subjects and this abnormality was related to the increase in body mass index and the arterial blood pressure. Thrombocyte NA and A, which is likely to re¯ect 24 h plasma catecholamine concentrations were reduced in obese subjects with a body fat % above 40%, probably due to a reduced physical activity in these subjects. Both catecholamine parameters were normalized by weight reduction.
Introduction
A low plasma adrenaline (A) concentration andaor low urinary excretion have been reported in obese subjects in several studies. 1, 2 We have previously shown that basal plasma A, increments in plasma A during sham-feeding and postprandial plasma A concentrations were reduced in women, who previously had been obese as compared to never-obese women. 2 These results indicated that women who previously had been obese responded differently to food stimulation than normal subjects.
The purpose of this present study was to compare resting forearm venous plasma NA concentrations with 24 h sympathoadrenal activity evaluated by measurements of thrombocyte NA and A in obese male subjects. The thrombocyte catecholamine level changes slowly in the course of one to two days in reponse to changes in plasma catecholamines, 3, 4 and may be a better index of chronic sympathoadrenal activity than resting forearm venous plasma catecholamines. Furthermore, thrombocyte NA and A levels may also be a better index of the mean 24 h sympathoadrenal activity than urinary excretion rates of catecholamines, because the latter is unlikely to include NA and A derived from the gastrointestinal tract. NA and A derived from the gastrointestinal tract are largely eliminated in the liver. Furthermore, we have found a close correlation between plasma and thrombocyte NA and between plasma and thrombocyte A in patients with pheochromocytoma. 5 In addition, we have measured cAMP and b 2 -adrenoceptor mRNA in obese male subjects and in controls. These variables were measured in lymphocytes and not in fat cells to avoid secondary changes due to fat accumulation.
We did not measure the clearance of NA, because the clearance concept cannot easily be applied to NA.
Furthermore, we did not use microneurography, because this technique cannot be applied to visceral organs in man.
Subjects and methods

Subjects and protocol
The protocol was approved by the local Ethics committee. Fifteen healthy obese male subjects with a mean age of 36.9 y (range 18 ± 48 y) and six healthy non-obese male subjects with a mean age of 33.5 y (range 22 ± 48 y) were investigated after they had given informed written consent. One of the obese subjects was subsequently shown to have an elevated plasma glucose concentration and was therefore excluded from the study. All subjects were nonsmokers. The diet was standardized 3 d prior to the blood sampling procedure. The composition of the diet was 15% protein, 35% fat and 50% of carbohydrate. All subjects fasted overnight. At 8 am a catheter was placed in an antecubital vein and the subjects rested in the supine position for 45 min, thereafter a blood sample was collected.
The following parameters were recorded or measured: Age (y), height (cm), body mass index (body weight in kga(height in m) 2 ), total body fat % and truncal body fat % by dexa-scanning, systolic and diastolic blood pressure (in mm Hg), plasma NA and A (in nmolal), thrombocyte NA and A (in pg per 10 8 thrombocytes), lymphocyte composition in peripheral venous blood as evaluated by FACS-scanning, lymphocyte cAMP in the basal state and after stimulation with isoprenaline, the frequency of residual thrombocytes in the lymphocyte preparation, the volume and frequency of thrombocytes in peripheral blood as well as b 2 -adrenoceptor mRNA as measured by RT-PCR and HPLC for separation of standard and unknown and for quanti®cation.
Twelve of the 14 subjects were available for study after they had participated in a weight reduction programme. The diet was a low fat diet and the subjects were examined after a 16 weeks period of weight loss followed by an 8 weeks weight stability period. Three of the non-obese subjects included in the ®rst study and four additonal non-obese subjects were included in the second study. The mean age of the second control group was 33.6 y (range 21 ± 44 y).
We studied the same parameters as in the ®rst part of the study with the exception of the lymphocytes.
Isolation of lymphocytes and thrombocytes
Blood for isolation of lymphocytes was sampled in glass tubes with EDTA as anticoagulant: Mononuclear cells mainly lymphocytes were isolated by density centrifugation on Lymphoprep TM (Nycomed Pharma, Oslo, Norway). Initially blood was layered on Lymphoprep TM and centrifuged for 30 min at 1400 rpm (394 g) and 21
C. Lymphocytes were isolated and washed three times in RPMI 1640 medium with hepes buffer (Life Technologies, Denmark) both with and without bovine serum albumin (0.5%) at 4 C. Erythrocytes and 99% of the thrombocytes were removed by the isolation procedure. The number of residual thrombocytes in the lymphocyte preparation was very low and similar in the two groups (0.6 AE 0.06 ( AE s.e.m.) and 0.5 AE 0.1 thrombocyte per lymphocyte in obese subjects and in controls, respectively). The lymphocyte cell concentration was adjusted and 2Â10 5 cells were used for¯owcytometric analysis and 5Â10 5 cells for cAMP studies.
Thrombocytes were isolated using low speed centrifugation (350 g), and washed three times with RPMI medium with hepes buffer without albumin. The number of thrombocytes were adjusted to 10 8 thrombocytes per tube. Samples were then drained, frozen in liquid nitrogen and stored at 7 80 C.
Measurements of catecholamines
Measurements of plasma NA and A. Plasma NA and A were measured by a radioenzymatic assay. 7 Blood was collected in ice-cold tubes containing EGTA and reduced glutathione. Cells and plasma were separated within 10 min in a refrigerated centrifuge and plasma stored at 7 80 C. Normetanephrine and metanephrine were separated by HPLC (Waters), and the 3 Hlabelled products were counted by liquid scintillation spectrometry.
Intra-assay coef®cients of variation for NA and A in samples containing normal basal values were 6% and 8%, respectively (n 10). Corresponding values of interassay coef®cients of variation for NA and A were 7% and 11%, respectively (n 0). The sensitivity of the assay, calculated as three times the standard deviation of the analytical blank was for intraassays 1.7 fmol and 3.0 fmolaassay for A and NA, respectively. Corresponding values for interassays were 2.8 and 3.0 fmolaassay for A and NA.
Measurements of unconjugated NA and A in thrombocytes. Blood was collected in tubes containing EDTA. Thrombocytes were isolated as described above and the number adjusted to 10 8 thrombocytes. The samples were centrifuged, drained and frozen. At the day of analysis 200 ml of a buffer containing albumin (6%) was added and samples were immediately precipitated with perchloric acid and homogenized. One hundred ml was used for analysis as described above.
Recovery of NA and A added to the thrombocyte preparation was 79AE 3.1% ( AE s.e.m.) and 84AE 2.5% (n 7). cAMP assay cAMP was measured by radioimmunoassay (Amersham, UK) in duplicate. cAMP was always measured
Resting and 24-hour sympathetic activity SB Sùndergaard et al in lymphocytes isolated without bovine serum albumin, because the presence of bovine serum albumin reduced the response. Phosphodiesterase was inhibited by preincubation for 15 min and 37 C with 1.5 mM 3-isobutyl-1-methylxanthine (IBMX) (Sigma Chemicals, St. Louis, MO., USA). Cells were stimulated with various concentrations of isoprenaline. The stimulation was stopped by the addition of two volumes of ethanol and freezing in liquid nitrogen.
Flowcytometric analysis of subset frequencies
Cells for¯owcytometry were incubated with¯uores-cent antibodies at 4 C for 30 min in HANKS with sodium azide 1.3 gal and then washed three times.
Subset frequencies were determined by¯owcyto-metry on a FACS (from Beckton Dickinson, USA) with 10 000 events per sample excluding debris. Scatter gates were set to exclude dead cells and debris during analysis. Subset frequencies were expressed in percent of mononuclear cells. A negative control (SIMULTEST) was included. NK cells were de®ned by CD3 7 CD56 or CD3 7 CD16 cells. T-cytotoxic cells were de®ned by CD3 CD8 and T-helper cells by CD3 CD4 . B-cells were CD(19 20) and monocytes were CD14 .
Quanti®cation of b 2 -adrenoceptor mRNA in lymphocytes b 2 -adrenoceptor mRNA in lymphocytes was quanti®ed by RT-PCR and HPLC. The technique has been described in detail elsewhere. 8, 9 Primers and the construction of internal standard
The oligonucleotide primers were synthesized at DNA Technology (Aarhus, Denmark). 5 H -primer: CGC TTC CAT GTC CAG AAC CT (nucleotide 715-734), 3 Hprimer: CTG TTC CAC GTG ATA TCC AC (nucleotide 1110-1091). Therefore the ampli®ed fragment consisted of the 396 basepairs 715 ± 1110.
With these primers we constructed an internal standard DNA using the PCR MIMIC TM construction kit from Clontech. The internal standard RNA was constructed mainly as described by Faure et al. 10 The resulting internal standard RNA was quanti®ed by UV-detection (Gene-Quant, Pharmacia, Sweden). The resulting RT-PCR product was indistinguishable from the internal standard DNA.
Isolation of mRNA
Polyadenylated RNA was isolated from lymphocytes using the QuickPrep 1 Micro mRNA Puri®cation Kit from Pharmacia Biotech.
Reverse transcription
The reverse transcription mixture contained: mRNA from up to 10 6 lymphocytes, 0.15 amol internal standard RNA, 225 pmol 3
H -primer, 1 mM of each dNTP, 60 U MMLV-RT (Promega), 40 U RNA-guard in 25 ml Promega RT-buffer (50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl 2 , 10 mM DTT). Incubation was at 37 C for 60 min, and the cDNA was stored frozen at 7 80 C or used immediately.
PCR
For the PCR reactions 3 ml cDNA aliquots (corresponding to 0.018 amol internal standard RNA added) were combined with 40 pmol of each primer, 150 mM of each dNTP, 1.0 U Taq polymerase (Pharmacia) in the supplied PCR reaction buffer, at 0 C in a volume of 100 ml, and overlayered with mineral oil.
C whereupon the temperature was lowered to 4 C. The PCR products were either used for HPLC immediately or stored frozen at 7 80 C.
Quanti®cation of PCR products by HPLC
The HPLC system consisted of a TSK 1 DEAE-NPR column (4.6 mm I.D.Â35 mm, with a short guard column), thermostated at 30 C. The mobile phase was a gradient: Buffer A: 25 mM Tris-HCl, pH 9.0, 1.0 M NaCl. Buffer B: 25 mM Tris-HCl, pH 9.0. The gradient was from 25 ± 56% A in 0.5 min, 58 ± 62% A in 6.5 min, 61 ± 70% A in 0.5 min, 70% A for 0.5 min, 70 ± 25% A in 0.5 min, 25% A in at least 3.5 min, all with a¯ow of 1.0 ml per min. The pump was a WATERS Model 616 gradient pump controlled by Millennium 1 version 2.15 software, which was also used for data acquisition and processing. Detection was by an Applied Biosystems Model 759A UVdetector at 254 nm.
The samples were heated to 60 C for 5 min immediately before injection. Ninety ml were injected by a manual injector. The 396 bp PCR product was quanti®ed relative to the 240 bp internal standard using areas and corrected for the different sizes of the two products.
Validation of the technique
The ampli®cation rate was exponential up to at least 27 cycles for both standard and unknown. The ampli®cation was close to the theoretical rate of 2 n (n number of cycles) which can be obtained. The standard curve was linear, provided the ratio of the cDNAastandard area was between 0.5 ± 4. When the calculated ratio exceeded this limit the sample was reanalysed with a reduced amount of mRNA added to RT.
Controls with no RT and no cDNA were run frequently. No contamination of sample mRNA with genomic DNA was observed. The sensitivity of the Resting and 24-hour sympathetic activity SB Sùndergaard et al assay was approximately 0.004 amol RNA corresponding to 5000 mAUÂs. Reproducibility. Intraassay and interassay coef®-cients of variations for the whole procedure (isolation of mRNA, RT and PCR) were 17% and 26%, respectively. The PCR procedure alone showed consistently a high degree of reproducibility (coef®cient of variation 6%).
Statistics
Mean differences between related samples were analysed by the t-test or the non-parametric Mann ± Whitney test. Differences between several unrelated samples were analysed by ANOVA. Correlations were performed using the Spearman Test (Rs). Linear regression (r) was also performed. Multiple regression analysis was performed by the SigmaStat programme version 1.02. A P value`0.05 was considered signi®cant. Table 1 shows pertinent clinical data. Truncal fat % in obese subjects was closely correlated to total body fat % (Rs 0.93, P`0.005). The correlation between BMI and body fat % was not signi®cant (Rs 0.49, P`0.075). Forearm venous plasma NA concentration was signi®cantly greater in obese subjects as compared to controls (P`0.01), whereas plasma A and thrombocyte NA and A were not signi®cantly different (Table 2) .
Results
Forearm venous plasma NA in obese subjects was signi®cantly correlated to BMI (Rs 0.56, P 0.04) and to the diastolic blood pressure (Rs 0.61, P`0.02). Thrombocyte NA and A in the same subjects were, however, negatively correlated to body fat % (Rs 70.67, P`0.01 and Rs 70.68, P`0.009, respectively, Figure 1 ) and to body weight (Rs 70.70, P`0.006 and Rs 70.78, P`0.001, respectively). Thrombocyte A was also negatively correlated to BMI (Rs 70.64, P`0.02).
Thrombocyte NA and A concentrations were closely correlated (Rs 0.91, P`0.005). Plasma and thrombocyte NA concentrations were also correlated (P`0.03) but only after a correction had been made by multiple regression analysis for the statistical effect of BMI. The frequency of thrombocytes in peripheral blood or thrombocyte volume were not different in obese and control subjects. ns not signi®cant. Figure 1 The relationship between the thrombocyte noradrenaline concentration (pg per 10 8 thrombocytes, divide by 169 to calculate pmol) plotted on the ordinate versus the body fat % plotted on the abscissa. Results were obtained in 14 obese subjects.
Resting and 24-hour sympathetic activity SB Sùndergaard et al There was no difference between cAMP in obese subjects and in controls (data not shown). BMI and cAMP were not correlated. b 2 -adrenoceptor mRNA in lymphocytes averaged 0.66 AE 0.07 ( AE s.e.m.) and 0.58AE 0.1 amol per 10 6 lymphocytes in obese and controls, respectively. This difference was not signi®cant.
Multiple regression analysis showed that b 2 -adrenoceptor mRNA in all subjects (n 20) was correlated with the frequency of both CD3 CD8 and CD3 7 CD56 (R 0.57; P`0.02 and 0.04, respectively). Both lymphocyte subsets had to be taken into account, because the frequency of CD3 CD8 and CD3 7 CD56 were negatively correlated. b 2 -adrenoceptor mRNA on the one hand and BMI, truncal fat % and total body fat % on the the other hand were not correlated. Plasma A correlated negatively to b 2 -adrenoceptor mRNA when data from both obese subjects and controls were included in the analysis (r 7 0.52, P`0.02, n 20).
There was no difference between lymphocyte subset composition in obese subjects and controls. The concentration of cAMP IBMX was correlated to the frequency of NK cells (CD3 7 CD56 ) (Rs 0.45, P`0.05, n 20).
Weight reduction. Twelve subjects were available for examination after the weight reduction programme. The mean decrease in the body weight averaged 20.2AE 2.8 kg (P`0.001). BMI averaged 31.7AE 1.3 and was still signi®cantly greater than in the control group (22.8AE 0.4, n 7, P`0.001).
Plasma NA decreased signi®catly after the weight loss to 0.65 AE 0.12 nmolal (P`0.009) and this value was not signi®cantly different from a mean value of 0.71AE 0.06 nmolal obtained in the new control group. Plasma A averaged 0.056AE 0.011 nmolal, a value not signi®cantly different from the value obtained before the weight loss.
The mean thrombocyte NA and A concentrations in the obese subjects after weight reduction were not different from the corresponding values obtained in the second control group (58.2 AE 8.6 and 4.5 AE 0.7 vs 58.7AE 4.8 and 4.9 AE 0.5 pg per 10 8 thrombocytes, respectively). Figure 2 and 3 shows the mean thrombocyte NA and A concentrations related to total body fat %. Thrombocyte NA and A concentrations were signi®-cantly reduced in the obese subjects with a fat % greater than 40 (P`0.03, P`0.04, respectively), but not in the two other groups.
In the four subjects who initially had a total body fat % above 40, the thrombocyte NA and A concentrations doubled after the weight loss. There was no change in thrombocyte NA and A after weight reduction in the obese subjects, who initially had a total fat % below 40.
After the weight loss plasma NA and thrombocyte NA were correlated by simple regression analysis and without correction for BMI (Rs 0.72, P`0.01).
Discussion
This present study indicated that obesity had different effects on resting forearm venous plasma NA and thrombocyte NA and A concentrations. Plasma NA concentrations increased positively with BMI, whereas thrombocyte NA and A decreased with increasing body fat %. Forearm venous plasma NA Results are mean AE s.e.m. The non-obese subjects included three subjects from the ®rst group, which was not included in the second group and all seven subjects from the second control group (n 10). In one of the subjects the body fat % was still above 40 after the weight reduction programme (n 11). Thrombocyte NA was signi®cantly reduced in the obese subjects with a body fat % b 40 (ANOVA, P`0.03). Resting and 24-hour sympathetic activity SB Sùndergaard et al and thrombocyte NA concentrations were correlated, however, provided the effect of obesity was taken into account in the multiple regression analysis. After weight loss both parameters were correlated by simple correlation analysis. The resting venous plasma NA is to a large extent derived from the forearm, which is composed mainly of muscle tissue indicating that muscle sympathetic activity was increased in proportion to the degree of obesity and the increase in the diastolic blood pressure.
Conclusions
A new ®nding in this present study is the negative correlation observed between thrombocyte NA as well as A and the total body fat %. This abnormality was only seen in subjects with the more severe degrees of obesity and NA and A values had returned to normal after the weight reduction programme. Thrombocyte catecholamines re¯ect long term (chronic) changes in plasma catecholamines. 3, 4 In a group of patients with pheochromocytoma and large differences in plasma NA and A we observed that the ratios between plasma and thrombocyte NA and between plasma and thrombocyte A were constant and similar to results obtained in normal subjects. 5 There are at least two possible explanations of the reduced thrombocyte NA and A in the obese subjects. Thrombocyte NA and A re¯ect 24 h plasma NA and A concentrations, which include the resting state but also physical activity associated with the upright posture and physical exercise. An upright posture requires a considerable increase in NA and A release, which is not observed during light exercise. With moderate to severe exercise plasma NA and A concentrations are also increased. Therefore, a reduced physical activity during the 24 h period may explain the reduced thrombocyte NA and A concentrations in the obese subjects.
We cannot exclude the possibility that the uptake of NA and A in thrombocytes was reduced by increasing BMI, but the thrombocyte volume and number in plasma were not correlated to BMI. Thrombocytes circulate through all parts of the body and the data are also compatible with the view that sympathoadrenal activity was reduced with increasing BMI in organs, in which plasma catecholamines are removed at the out¯ow. Sympathetic activity in the gastrointestinal tract cannot be detected in peripheral plasma, because the extraction ratio of NA and A in the liver is very high. Therefore, our data may suggest that sympathoadrenal activity to the visceral organs including the adrenal medulla was reduced in subjects with the most severe degree of obesity. In contrast to ®ndings in postobese women mentioned above, this study in obese male subjects suggests, that the abnormality in thrombocyte catecholamines was secondary to the degree of obesity, because thrombocyte catecholamines were normalized after the weight reduction programme even though the body fat % had not been completely normalized.
The concentration of cAMP in lymphocytes was not different in obese and in controls neither in the basal state nor after stimulation with isoprenaline, indicating that there was no general abnormality in b 2 -adrenoceptor function in the obese subjects. The b 2 -adrenoceptor mRNA concentration was also similar in obese and non-obese subjects. The b 2 -adrenoceptor concentration correlated to the frequency of NK (natural killer) cells in the blood and cytotoxic Tcells (CD3 CD8 ). This ®nding is in accordance with the fact that these cells contain the greatest number of b 2 -adrenoceptor. The positive correlation observed between cAMP and the frequency of NK cells in the blood con®rms our previous ®ndings. 
